L-tryptophan contaminant peak E and interleukin-5 production from T cellsYAMAOKA, K. A; MIYASAKA, N; KASHIWAZAKI, S et al.Lancet (British edition). 1991, Vol 338, Num 8780, issn 0140-6736, p. 1468Article

Interleukin-5, eosinophils, and diseaseSANDERSON, C. J.Blood. 1992, Vol 79, Num 12, pp 3101-3109, issn 0006-4971Article

Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1αVAN DER BRUGGEN, T; CALDENHOVEN, E; KANTERS, D et al.Blood. 1995, Vol 85, Num 6, pp 1442-1448, issn 0006-4971Article

Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjectsSEHMI, R; WARDLAW, A. J; CROMWELL, O et al.Blood. 1992, Vol 79, Num 11, pp 2952-2959, issn 0006-4971Article

Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophiliaBUTTERFIELD, J. H; LEIFERMAN, K. M; ABRAMS, J et al.Blood. 1992, Vol 79, Num 3, pp 688-692, issn 0006-4971Article

Cytokine recognition by human interleukin 5 receptorISHINO, Tetsuya; ROBERTSON, Noreen; CHAIKEN, Irwin et al.Vitamins and hormones. 2005, Vol 71, pp 321-344, issn 0083-6729, 24 p.Article

Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activityREIMAN, Rachael M; THOMPSON, Robert W; FENG, Carl G et al.Infection and immunity. 2006, Vol 74, Num 3, pp 1471-1479, issn 0019-9567, 9 p.Article

Modulation of eosinophil chemotaxis by interleukin-5WARRINGA, R. A. J; SCHWEIZER, R. C; MAIKOE, T et al.American journal of respiratory cell and molecular biology. 1992, Vol 7, Num 6, pp 631-636, issn 1044-1549Article

Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor outputBEEKMAN, Jeffrey M; VERHAGEN, Liesbeth P; GEIJSEN, Niels et al.Blood. 2009, Vol 114, Num 18, pp 3917-3927, issn 0006-4971, 11 p.Article

Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4FUJIHASHI, K; BEAGLEY, K. W; KONO, Y et al.The American journal of pathology. 1993, Vol 142, Num 4, pp 1239-1250, issn 0002-9440Article

Characterization of a receptor for interleukin-5 on human eosinophils and the myeloid leukemia line HL-60INGLEY, E; YOUNG, I. G.Blood. 1991, Vol 78, Num 2, pp 339-344, issn 0006-4971Article

Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal AntibodySMITH, Deborah A; MINTHORN, Elisabeth A; BEERAHEE, Misba et al.Clinical pharmacokinetics. 2011, Vol 50, Num 4, pp 215-227, issn 0312-5963, 13 p.Article

Isolation of human eosinophils: microbead method has no impact on IL-5 sustained viabilityPERCOPO, Caroline M; DYER, Kimberly D; KILLORAN, Kristin E et al.Experimental dermatology. 2010, Vol 19, Num 5, pp 467-469, issn 0906-6705, 3 p.Article

Th2-polarisation of cellular immune memory to neonatal pertussis vaccinationWHITE, Olivia J; ROWE, Julie; RICHMOND, Peter et al.Vaccine. 2010, Vol 28, Num 14, pp 2648-2652, issn 0264-410X, 5 p.Article

IL-3, IL-5, and GM-CSF signaling : Crystal structure of the human beta-common receptorMURPHY, James M; YOUNG, Ian G.Vitamins and hormones. 2006, Vol 74, pp 1-30, issn 0083-6729, 30 p.Article

IL-5 and its receptor : which role do they play in the immune response ?KOIKE, M; TAKATSU, K.International archives of allergy and immunology. 1994, Vol 104, Num 1, pp 1-9, issn 1018-2438Article

The biology of the eosinophilic leukocyteGLEICH, G. J; ADOLPHSON, C. R; LEIFERMAN, K. M et al.Annual review of medicine. 1993, Vol 44, pp 85-101, issn 0066-4219Article

Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseasesDESREUMAUX, P; JANIN, A; DUBUCQUOI, S et al.Blood. 1993, Vol 82, Num 5, pp 1553-1560, issn 0006-4971Article

Enhancement of human basophil histamine release by interleukin 5HIRAI, K; YAMAGUCHI, M; MISAKI, Y et al.The Journal of experimental medicine. 1990, Vol 172, Num 5, pp 1525-1528, issn 0022-1007, 4 p.Article

Electrical immunosensor based on a submicron-gap interdigitated electrode and gold enhancementJUNHYOUNG AHN; TAE HAN LEE; TAIHUA LI et al.Biosensors & bioelectronics. 2011, Vol 26, Num 12, pp 4690-4696, issn 0956-5663, 7 p.Article

Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndromeKLION, Amv D; LAW, Melissa A; NOEL, Pierre et al.Blood. 2004, Vol 103, Num 8, pp 2939-2941, issn 0006-4971, 3 p.Article

Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitisPLÖTZ, Sabine-Gisela; SIMON, Hans-Uwe; DARSOW, Ulf et al.The New England journal of medicine. 2003, Vol 349, Num 24, pp 2334-2339, issn 0028-4793, 6 p.Article

Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectorsRAMSAY, A. J; KAH-HOO LEONG; BOYLE, D et al.Reproduction, fertility and development. 1994, Vol 6, Num 3, pp 389-392, issn 1031-3613Conference Paper

Abnormal response to IL-5 in B-cell chronic lymphocytic leukemiaHAYES, T. G; XIAO-LIN TAN; MOSELEY, A. B et al.Leukemia research. 1993, Vol 17, Num 9, pp 777-783, issn 0145-2126Article

Strategies of anti-cytokine monoclonal antibody development : immunoassay of IL-10 and IL-5 in clinical samplesABRAMS, J. S; RONCAROLO, M.-G; YSSEL, H et al.Immunological reviews. 1992, Vol 127, pp 5-24, issn 0105-2896Article